Bn II System
Payments companies reported to CMS as associated with Bn II System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Bn II System, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Bn II System
These are the largest totals companies reported as associated with Bn II System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| David Keren | Ann Arbor, MI | Anatomic Pathology & Clinical Pathology | $1,000.00 |
| Giovanni Lujan | Columbus, OH | Anatomic Pathology & Clinical Pathology | $229.66 |
| Coy Gammage | Monroe, LA | Hematology & Oncology | $87.91 |
| Pavan Katikaneni | Shreveport, LA | Interventional Cardiology | $58.91 |
| Prakash Peddi | Shreveport, LA | Hematology & Oncology | $58.91 |
| Raymond Elsoueidi | Hazard, KY | Hematology & Oncology | $36.17 |
| Samuel Bailey | Hazard, KY | Hematology & Oncology | $36.17 |
| Deborah Gordon | Gardner, MA | Anatomic Pathology & Clinical Pathology | $22.80 |
| Mark Mangano | Milford, MA | Anatomic Pathology & Clinical Pathology | $22.80 |
| Rochelle Freire | Miami, FL | Anatomic Pathology & Clinical Pathology | $22.40 |
Prescribed Bn II System?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.